February 8, 2011 Development and Evaluation of a Genomic Signature for the Prediction and Mechanistic Assessment of Nongenotoxic Hepatocarcinogens in the Rat
January 12, 2011 Patient Self-report for Evaluating Mild Cognitive Impairment and Prodromal Alzheimer’s Disease
October 5, 2010 Urinary Clusterin, Cystatin C, [beta]2-Microglobulin and Total Protein as Markers to Detect Drug-Induced Kidney Injury
October 5, 2010 Renal Biomarker Qualification Submission: A Dialog Between the FDA-EMEA and Predictive Safety Testing Consortium
January 9, 2010 Pharmacometrics As A Discipline Is Entering The “Industrialization” Phase: Standards, Automation, Knowledge Sharing, And Training Are Critical For Future Success
Opportunities and Challenges of Safety Biomarker Qualification: Perspectives from the Predictive Safety Testing Consortium